Finally, we will discuss the translational impact of these findings by evidencing the different mechanisms of action of drugs that are able to counteract the leptin-mediated effects and which may overcome the interplay between obesity and cancer. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.